PortfoliosLab logoPortfoliosLab logo
NEFRX vs. PCLIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NEFRX vs. PCLIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loomis Sayles Core Plus Bond Fund (NEFRX) and PIMCO CommoditiesPLUS Strategy Fund (PCLIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NEFRX achieves a 0.31% return, which is significantly lower than PCLIX's 36.81% return. Over the past 10 years, NEFRX has underperformed PCLIX with an annualized return of 2.17%, while PCLIX has yielded a comparatively higher 12.24% annualized return.


NEFRX

1D
0.09%
1M
0.45%
YTD
0.31%
6M
0.08%
1Y
5.38%
3Y*
3.62%
5Y*
0.04%
10Y*
2.17%

PCLIX

1D
0.54%
1M
-3.72%
YTD
36.81%
6M
35.82%
1Y
46.35%
3Y*
18.54%
5Y*
16.85%
10Y*
12.24%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NEFRX vs. PCLIX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NEFRX
Loomis Sayles Core Plus Bond Fund
0.31%7.24%0.60%5.91%-12.94%-1.68%10.29%8.76%-0.86%4.92%
PCLIX
PIMCO CommoditiesPLUS Strategy Fund
36.81%5.76%8.53%0.69%23.32%43.83%-9.18%19.37%-12.02%10.86%

Correlation

The correlation between NEFRX and PCLIX is -0.25, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.25

Correlation (3Y)
Calculated over the trailing 3-year period

-0.10

Correlation (5Y)
Calculated over the trailing 5-year period

-0.06

Correlation (10Y)
Calculated over the trailing 10-year period

-0.04

Correlation (All Time)
Calculated using the full available price history since Jun 2, 2010

-0.04

Over the past year, the inverse relationship between NEFRX and PCLIX has strengthened: their correlation has moved from -0.04 to -0.25, meaning they now move in opposite directions more often than their long-term average.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEFRX vs. PCLIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEFRX
NEFRX Risk / Return Rank: 3131
Overall Rank
NEFRX Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
NEFRX Sortino Ratio Rank: 3333
Sortino Ratio Rank
NEFRX Omega Ratio Rank: 2929
Omega Ratio Rank
NEFRX Calmar Ratio Rank: 3535
Calmar Ratio Rank
NEFRX Martin Ratio Rank: 2727
Martin Ratio Rank

PCLIX
PCLIX Risk / Return Rank: 7575
Overall Rank
PCLIX Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
PCLIX Sortino Ratio Rank: 5454
Sortino Ratio Rank
PCLIX Omega Ratio Rank: 6161
Omega Ratio Rank
PCLIX Calmar Ratio Rank: 9797
Calmar Ratio Rank
PCLIX Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEFRX vs. PCLIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Core Plus Bond Fund (NEFRX) and PIMCO CommoditiesPLUS Strategy Fund (PCLIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NEFRXPCLIXDifference

Sharpe ratio

Return per unit of total volatility

1.55

2.47

-0.92

Sortino ratio

Return per unit of downside risk

2.40

3.11

-0.72

Omega ratio

Gain probability vs. loss probability

1.28

1.44

-0.15

Calmar ratio

Return relative to maximum drawdown

2.22

7.01

-4.78

Martin ratio

Return relative to average drawdown

6.44

17.91

-11.48

NEFRX vs. PCLIX - Sharpe Ratio Comparison

The current NEFRX Sharpe Ratio is 1.55, which is lower than the PCLIX Sharpe Ratio of 2.47. The chart below compares the historical Sharpe Ratios of NEFRX and PCLIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NEFRXPCLIXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.55

2.47

-0.92

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.01

0.87

-0.87

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

0.30

+0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

0.74

0.18

+0.56

Drawdowns

NEFRX vs. PCLIX - Drawdown Comparison

The maximum NEFRX drawdown since its inception was -25.45%, smaller than the maximum PCLIX drawdown of -66.60%. Use the drawdown chart below to compare losses from any high point for NEFRX and PCLIX.


Loading charts...

Drawdown Indicators


NEFRXPCLIXDifference

Max Drawdown

Largest peak-to-trough decline

-25.45%

-66.60%

+41.15%

Max Drawdown (1Y)

Largest decline over 1 year

-2.92%

-6.84%

+3.92%

Max Drawdown (3Y)

Largest decline over 3 years

-7.95%

-12.30%

+4.35%

Max Drawdown (5Y)

Largest decline over 5 years

-18.55%

-21.59%

+3.04%

Max Drawdown (10Y)

Largest decline over 10 years

-18.76%

-51.78%

+33.02%

Current Drawdown

Current decline from peak

-1.89%

-4.70%

+2.81%

Average Drawdown

Average peak-to-trough decline

-3.97%

-24.15%

+20.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.17%

2.67%

-1.50%

Volatility

NEFRX vs. PCLIX - Volatility Comparison

The current volatility for Loomis Sayles Core Plus Bond Fund (NEFRX) is 1.36%, while PIMCO CommoditiesPLUS Strategy Fund (PCLIX) has a volatility of 6.97%. This indicates that NEFRX experiences smaller price fluctuations and is considered to be less risky than PCLIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NEFRXPCLIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

1.36%

6.97%

-5.61%

Volatility (6M)

Calculated over the trailing 6-month period

2.73%

16.87%

-14.14%

Volatility (1Y)

Calculated over the trailing 1-year period

4.19%

19.49%

-15.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

6.23%

19.41%

-13.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

5.04%

40.55%

-35.51%

NEFRX vs. PCLIX - Expense Ratio Comparison

NEFRX has a 0.71% expense ratio, which is lower than PCLIX's 0.98% expense ratio.


Dividends

NEFRX vs. PCLIX - Dividend Comparison

NEFRX's dividend yield for the trailing twelve months is around 3.61%, more than PCLIX's 1.37% yield.


PositionTTM20252024202320222021202020192018201720162015
NEFRX
Loomis Sayles Core Plus Bond Fund
3.61%3.97%3.90%3.58%3.10%2.34%4.04%2.51%2.87%2.68%3.17%2.58%
PCLIX
PIMCO CommoditiesPLUS Strategy Fund
1.37%2.45%7.50%5.06%42.60%73.41%0.77%2.46%18.58%12.63%0.16%2.22%

Frequently Asked Questions


NEFRX and PCLIX have a correlation of -0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PCLIX has higher volatility (6.97%) compared to NEFRX (1.36%). In terms of maximum drawdown, NEFRX dropped -25.45% vs PCLIX's -66.60%.

PCLIX currently has the higher Sharpe Ratio (2.47 vs 1.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NEFRX and PCLIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer